Before Your Appointment
Print or save the trial details from your search results. Most trial listings include the NCT number (a unique identifier), the study protocol, eligibility criteria, and the research site locations. Having these on hand makes your conversation specific rather than abstract.
Questions to Ask Your Hematologist
These questions can help you and your doctor evaluate whether a specific trial makes sense for your situation:
- "Am I eligible for this trial based on my current bloodwork and treatment history?" — Your doctor can quickly cross-reference your labs with the trial's inclusion/exclusion criteria.
- "How would this trial compare to my current treatment plan?" — This helps you understand the potential benefits and trade-offs relative to what's already working (or not working).
- "What would participation require in terms of time and travel?" — Some trials require frequent site visits, blood draws, or bone marrow biopsies. Your doctor can help you assess the practical burden.
- "Are there any risks specific to my MPN subtype or disease stage?" — Risk profiles vary significantly between early-stage PV and advanced myelofibrosis. Your doctor knows your individual risk factors.
- "Would you recommend any other trials I haven't found?" — Hematologists often know about trials through professional networks before they're widely listed. They may suggest options you missed.
Remember: You Are Your Own Best Advocate
Clinical trials are voluntary. You can withdraw at any time. A good trial team will never pressure you, and your hematologist should support your decision either way. If you feel uncertain, ask for a second opinion from an MPN specialist.
After Your Conversation
If you and your doctor agree a trial is worth pursuing, the next step is usually contacting the research site directly. Most trial listings include a phone number or email for the study coordinator. Your doctor's office can also make a referral on your behalf — which sometimes speeds up the screening process.